INNsight Newsletter - October Edition

Welcome to the October edition of INNsight Newsletter, where we share with you the latest news and insights from?IQVIA Global Market Insights.?

This month's thought leadership includes:

• Orphan Drug Exclusivity:??A Lifeline for Rare Disease Patients
• ChannelDynamics? Global Reference 2024
• Powering Launch Excellence with Patient Engagement and Support (PES) Programmes
• Webinar:?CPH ChannelDynamics Verbatim with IQVIA AI Assistant: Transforming HCP Message Recall Analysis

Orphan Drug Exclusivity: A Lifeline for Rare Disease Patients

Discover the impact of Orphan Drug Exclusivity (ODE), a crucial protection that encourages innovation in rare disease treatments. ODE works independently or alongside other protections like Reference Product Exclusivity (RPE) and market protection, each with separate expiration dates. This exclusivity prevents any sponsor from producing the same drug for the same disease, even without using the original innovator’s data. Learn more

ChannelDynamics Global Reference 2024

This comprehensive report provides deep insights into 2023 pharmaceutical sales force and marketing channel performance trends. It highlights key metrics and visualizations, including marketing channel spend, HCP preferences, and digital engagement sources. Explore unique data to inform your strategic decisions in the life sciences industry to stay ahead with the latest analysis.? Learn more

Powering Launch Excellence with Patient Engagement and Support (PES) Programmes

A tough launch environment means many innovators do not achieve the anticipated RoI and patients and healthcare systems do not reap the full benefit of innovative therapies.??This paper discusses the intersect between launch performance and patient-reported unmet need and explores how providing patients with carefully tailored support can provide the necessary edge for new launches. Learn more

WEBINAR: ChannelDynamics Verbatim with IQVIA AI Assistant: Transforming HCP Message Recall Analysis

Next Tuesday, October 29, 2024, 10:00 AM EDT, 45 minutes

Don't miss out on next week’s exclusive webinar to discover how AI can uncover powerful HCP insights, guiding your brand planning and giving you a competitive edge for 2025 and beyond.

See how fast and accurate AI, powered by unparalleled IQVIA data, can:

• Summarize in seconds the key message themes recalled by HCPs for own and competitor brands – with data available across 800 therapy areas
• Identify the messages most strongly associated with HCPs’ intent to start or increase prescribing of your brand and rivals
• Reveal why interactions receive positive or negative NPS responses, highlighting your competitive strengths or weaknesses
• Highlight differences in message recall and impact across channels, time periods, countries and specialties

If you can't join us live, register anyway to receive the on-demand recording after the event. Register now

To learn about IQVIA Global Market Insights' solutions and how we can support your business, follow this link.